Skip to content
Open Data Finder
Open Government Canada

Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP)

Published by Health Canada | Santé Canada

About this dataset

Drugs are authorized for sale in Canada once they have successfully gone through the drug review process, which includes the assessment of the safety, efficacy and quality of the drug. However, Health Canada's SAP allows practitioners to request access to drugs that are not available in Canada for the emergency treatment of patients with serious or life-threatening conditions who have exhausted other treatment options.

Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access … · Open Data Finder